BAUDAX BIO INC (BXRX) Stock Analyst Ratings
NASDAQ:BXRX - Nasdaq - US07160F4046 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 43% to BXRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 24.48. This target is 13033.05% above the current price.
BXRX was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about BXRX.
In the previous month the buy percentage consensus was at a similar level.
BXRX was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-01-03 | Noble Capital Markets | Downgrade | Outperform -> Market Perform |